These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2899658)

  • 1. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].
    Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A
    Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
    Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

  • 9. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.
    Reubi JC
    Acta Endocrinol (Copenh); 1985 May; 109(1):108-14. PubMed ID: 2860768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
    Longnecker SM
    Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
    Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
    N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
    Alberts AS; Falkson G
    S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide: Jack-of-all-trades or expensive orphan?
    Offerhaus L
    Neth J Med; 1988 Jun; 32(5-6):265-9. PubMed ID: 2899297
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.
    Hearn PR; Ahmed M; Woodhouse NJ
    Horm Res; 1988; 29(5-6):211-3. PubMed ID: 2851522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
    Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
    Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
    Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
    Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
    Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
    Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Attempt in treating benign insulinoma by delayed somatostatin. 2 cases].
    Picq R; Vialettes B; de la Tour d'Auvergne M; Joliot AY; Vague P
    Presse Med; 1988 Nov; 17(39):2087. PubMed ID: 2849769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.